二次性副甲状腺機能亢進症（2HPT）に対するビタミンD維持療法

基本情報

NCT ID

NCT00828347

ステータス

完了

試験のフェーズ

該当なし

試験タイプ

介入

目標被験者数

35

治験依頼者名

Kumamoto University

概要

There are still no established protocols for maintenance therapy with intravenous or oral vitamin D preparations after the iPTH target has been achieved. Therefore, the present study compared the efficacy of two maintenance therapy protocols, i.e., oral administration of alfacalcidol (an oral vitamin D preparation) at a dose of 1.0 ug/day (higher-dose group) or at a dose of 0.25 ug/day (lower-dose group), in patients with secondary hyperparathyroidism who responded to initial maxacalcitol therapy, resulting in the control of iPTH to \< 150 pg/mL.

対象疾患

介入

依頼者（Sponsor）

実施施設 (1)